Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, has announced the US launch of INHANCE INTACT, a proprietary complete instrumentation system specifically developed for subscapularis-sparing total shoulder arthroplasty (TSA). The system enables surgeons to replace a damaged shoulder joint while keeping the shoulder muscle intact.

While effective, the traditional TSA deltopectoral approach to treat degenerative conditions like osteoarthritis and rotator cuff tears often requires detachment of the subscapularis tendon, a key muscle at the front of the shoulder that has been linked to post-operative pain, instability, and tendon failure. As a result, patients often face up to six weeks of post-operative immobilisation.

The tissue-sparing approach achieved with INHANCE INTACT instrumentation allows surgeons to perform shoulder replacement procedures with enhanced joint visualisation. Moreover, this approach enables patient shoulder movement as early as day one post-op. This faster rehabilitation supports the shift toward outpatient, minimally invasive care, making INHANCE INTACT ideal for Ambulatory Surgery Centres. By reducing pain and immobilization time, the system helps patients return to work, family and daily routines sooner.

“The introduction of INHANCE INTACT marks an important step forward in advancing shoulder care through thoughtful, clinically driven innovation. By offering solutions to surgeons that allow their patients to have immediate mobility, we’re expanding what’s possible for surgeons and strengthening an approach designed to improve outcomes, accelerate recovery, and support the shift to outpatient care,” said Sharrolyn Josse, Worldwide President, Joint Reconstruction, Johnson & Johnson MedTech.

Designed for use with the INHANCE Shoulder System, INHANCE INTACT integrates a stemless implant, 43 purpose-built instruments, and TRUMATCH Personalised Solutions to support anatomic precision, bone preservation, and surgical accuracy through patient-specific 3D planning. Together, the full procedural solution enables surgeons to deliver consistent results across a broad range of care settings.

INHANCE INTACT is now commercially available in the US.